These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7226975)

  • 1. Role of Staphylococcus aureus exfoliatin toxin in staphylococcal infections in mice.
    Shibl AM
    Chemotherapy; 1981; 27(3):224-7. PubMed ID: 7226975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcal scalded skin syndrome in two immunocompetent adults caused by exfoliatin B-producing Staphylococcus aureus.
    Opal SM; Johnson-Winegar AD; Cross AS
    J Clin Microbiol; 1988 Jul; 26(7):1283-6. PubMed ID: 3137245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies of exfoliatin producing Staphylococcus aureus isolated from various diseases (author's transl)].
    Futaki S; Hirayama K; Ichizawa Y; Hosoya R; Sarai Y
    Nihon Hifuka Gakkai Zasshi; 1977 Sep; 87(10):609-16. PubMed ID: 303712
    [No Abstract]   [Full Text] [Related]  

  • 4. Importance of exfoliatin toxin A production by Staphylococcus aureus strains isolated from clustered epidemics of neonatal pustulosis.
    Kaplan MH; Chmel H; Hsieh HC; Stephens A; Brinsko V
    J Clin Microbiol; 1986 Jan; 23(1):83-91. PubMed ID: 3700612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: report of a clinical failure.
    Levin TP; Suh B; Axelrod P; Truant AL; Fekete T
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1222-4. PubMed ID: 15728934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staphylococcal scalded skin syndrome I. Purification of exfoliatin and maternal transmission of neutralizing ability against exfoliatin.
    Nishioka K; Nakano T; Hirao N; Asada Y
    J Dermatol; 1977 Feb; 4(1):13-8. PubMed ID: 16688917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clindamycin as an anti-staphylococcal agent--indications and limitations.
    Hedström SA
    Scand J Infect Dis Suppl; 1984; 43():62-6. PubMed ID: 6598522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clindamycin-induced suppression of toxic-shock syndrome--associated exotoxin production.
    Schlievert PM; Kelly JA
    J Infect Dis; 1984 Mar; 149(3):471. PubMed ID: 6715902
    [No Abstract]   [Full Text] [Related]  

  • 9. Clindamycin treatment of experimental chronic osteomyelitis due to Staphylococcus aureus.
    Norden CW; Shinners E; Niederriter K
    J Infect Dis; 1986 May; 153(5):956-9. PubMed ID: 3701108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further observations of Corynebacterium renale as an indicator organism in the detection of the exfoliation-positive strains of Staphylococcus aureus.
    Skalka B; Pillich J; Pospísil L
    Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Dec; 256(2):168-74. PubMed ID: 6369832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel method for rapid production and purification of exfoliative toxin A of Staphylococcus aureus.
    Ladhani S; Cameron J; Chapple DS; Garratt RC; Joannou CL; Evans RW
    FEMS Microbiol Lett; 2002 Jun; 212(1):35-9. PubMed ID: 12076784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The search for strains of Staphylococcus aureus producing exfoliative toxin].
    Brevis P; Padilla C; Herrera R; Goset C
    Rev Latinoam Microbiol; 1988; 30(1):1-4. PubMed ID: 3140339
    [No Abstract]   [Full Text] [Related]  

  • 13. Nonenteric toxins of Staphylococcus aureus.
    Rogolsky M
    Microbiol Rev; 1979 Sep; 43(3):320-60. PubMed ID: 161608
    [No Abstract]   [Full Text] [Related]  

  • 14. Activity of erythromycin and clindamycin in an experimental Staphylococcus aureus infection in normal and granulocytopenic mice. A comparative in vivo and in vitro study.
    Hoogeterp JJ; Mattie H; van Furth R
    Scand J Infect Dis; 1993; 25(1):123-32. PubMed ID: 8460336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Panton-Valentine leucocidin expression by Staphylococcus aureus exposed to common antibiotics.
    Turner CE; Sriskandan S
    J Infect; 2015 Sep; 71(3):338-46. PubMed ID: 26028260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance.
    Drinkovic D; Fuller ER; Shore KP; Holland DJ; Ellis-Pegler R
    J Antimicrob Chemother; 2001 Aug; 48(2):315-6. PubMed ID: 11481309
    [No Abstract]   [Full Text] [Related]  

  • 17. Recurrent primary abscesses in the hand: consider panton-valentine leukocidin-positive Staphylococcus aureus.
    Wearn CM; Breuning EE; Chester DL
    J Hand Surg Eur Vol; 2015 Mar; 40(3):314-5. PubMed ID: 23461911
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prevalence of exfoliatin-producing strains in phage group II "Staphylococcus aureus" (author's transl)].
    Fleurette J; Ritter J
    Ann Microbiol (Paris); 1980; 131B(2):175-83. PubMed ID: 6450560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin findings of Staphylococcus aureus toxin-mediated infection in relation to toxin encoding genes.
    Courjon J; Hubiche T; Phan A; Tristan A; Bès M; Vandenesch F; Etienne J; Del Giudice P; Gillet Y
    Pediatr Infect Dis J; 2013 Jul; 32(7):727-30. PubMed ID: 23446443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An electron microscopic study of the effect of clindamycin therapy on bacterial adherence and glycocalyx formation in experimental Staphylococcus aureus osteomyelitis.
    Mayberry-Carson KJ; Tober-Meyer B; Lambe DW; Costerton JW
    Microbios; 1986; 48(196-197):189-206. PubMed ID: 3796304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.